切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2013, Vol. 01 ›› Issue (01) : 47 -50. doi: 10.3877/cma.j.issn.2095-655X.2013.01.010

所属专题: 总编推荐 文献

临床研究

健康体检人群体重指数与血脂水平及非酒精性脂肪肝关系的研究
邢燕1, 叶山东1,(), 洪海鸥1, 陈燕1   
  1. 1. 230001 合肥,安徽省立医院内分泌科 健康体检中心
  • 收稿日期:2013-10-20 出版日期:2013-11-26
  • 通信作者: 叶山东
  • 基金资助:
    安徽省年度重点科研基金(11070403035)

The relationship between body mass index, lipid profile and non-alcoholic fatty liver disease in healthy check-up crowd

Yan Xing1, Shandong Ye1,(), Haiou Hong1, Yan Chen1   

  1. 1. Department of Endocrinology, Anhui Provincial Hospital, Hefei 230001, China
  • Received:2013-10-20 Published:2013-11-26
  • Corresponding author: Shandong Ye
  • About author:
    Corresponding author: Ye Shandong, Email:
引用本文:

邢燕, 叶山东, 洪海鸥, 陈燕. 健康体检人群体重指数与血脂水平及非酒精性脂肪肝关系的研究[J/OL]. 中华诊断学电子杂志, 2013, 01(01): 47-50.

Yan Xing, Shandong Ye, Haiou Hong, Yan Chen. The relationship between body mass index, lipid profile and non-alcoholic fatty liver disease in healthy check-up crowd[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2013, 01(01): 47-50.

目的

探讨体重指数与血脂水平及非酒精性脂肪肝(non-alcoholic fatty liver disease, NAFLD)的关系。

方法

对2012年1月至2013年1月于安徽省立医院参加健康体检,病史及饮酒史资料完整的10000名体检者的人体质量指数(BMI)与其相关临床指标进行统计分析。按照BMI将人群分组,不同体重指数人群间血脂水平及NAFLD检出率差异采用χ2检验。

结果

(1)所有体检人群中超重及肥胖者5996例,占60%,正常体重者3829例,占38.3%;(2)超重和肥胖在不同年龄组人群中的构成比差异有统计学意义(χ2=161.733,P=0.000;(3)除高密度脂蛋白(HDL-C)外,超重组和肥胖组的甘油三脂(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)水平均明显高于体重正常组;(4)NAFLD和高脂血症的发生率随BMI水平升高而逐渐增加;(5)性别(男性)、BMI、TG、TC为NAFLD发生的独立危险因素,HDL-C为保护因素;(6)ROC曲线分析BMI预测NAFLD发生的最佳切点为(男性:24.85或24.95;女性24.95)。

结论

超重及肥胖是发生NAFLD和高脂血症的危险因素,应加强对体重的干预,以改善脂代谢和降低NAFLD的发生。

Objective

To analyze the relationship between body mass index, lipid profile and non-alcoholic fatty liver disease (NAFLD).

Methods

A population-based, cross-sectional study was carried out in 10 000 clients of health examination in the population of Hefei area in 2012. Body mass index (BMI), history of alcohol intake and past medical history were recorded. Subjects were divided into four groups according to the levels of BMI, clinical indicators included serum lipids, and fasting blood glucose and the rate of non-alcoholic fatty liver disease were compared among the four groups. Distribution of BMI of the masses in Hefei region was analyzed. The relationships between BMI and the incidences of hyperlipidemia and non-alcoholic fatty liver disease were discussed.

Results

(1)The occurring rate of obesity and overweight was 60%, normal weight was 38.3%. (2)The incidence of overweight and obesity was distinct in different age groups (χ2=161.733, P=0.000). (3)Except for high density lipoprotein-cholesterol, indicators included triglyceride, total cholesterol, low density lipoprotein-cholesterol, fasting blood sugar and uric acid levels in overweight and obesity groups were significantly higher than those in normal group. (4)With the increasing of BMI, the incidence of non-alcoholic fatty liver disease and hyperlipidemia were increased. (5)Factors including BMI, gender (male), triglyceride, total cholesterol were independent risk for non-alcoholic fatty liver disease, whereas high density lipoprotein cholesterol was a protective factor. (6)ROC analysis demonstrated that the best cut off value of BMI in predicting the incidence of non-alcoholic fatty liver disease was 24.85 or 24.95 in male and 24.95 in female.

Conclusions

Overweight and obesity are the risk factors for the prevalence of NAFLD and hyperlipidemia. Management of weight and targeted interventions rectifying the metabolism disorders at the earliest opportunity, which may contribute to reduce the risk of hyperlipidemia and NAFLD.

表1 不同年龄组健康体检者体重指数(BMI)分布情况比较
表2 健康体检人群不同人体质量指数(BMI)组血脂水平比较(中位数)
表3 健康体检人群不同人体质量指数(BMI)组高脂血症和非酒精性脂肪肝(NAFLD)发生率比较
[1]
Popkin BM. Does global obesity represent a global public health challenge?[J] Am J Clin Nutr, 2011, 93(2): 232-233.
[2]
Day K,Alfonzo M,Chen Y, et al. Overweight, obesity, and inactivity and urban design in rapidly growing Chinese cities[J]. Health Place, 2013, 21C: 29-38.
[3]
Park JS,Seo JH,Youn HS. Gut Microbiota and clinical disease:obesity and nonalcoholic fatty liver disease. Pediatr Gastroenterol Hepatol Nutr[J]. 2013, 16(1): 22-27.
[4]
中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志.2007, 35(5): 390-419.
[5]
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中华肝脏病杂志, 2010, 18(3): 163-166.
[6]
Gorman A,Kaye EK,Apovian C, et al. Overweight and obesity predict time to periodontal disease progression in men[J]. J Clin Periodontol, 2012, 39(2): 107-114.
[7]
Cai L,He J,Song Y, et al.Association of obesity with socio-economic factors and obesity-related chronic diseases in rural southwest China[J]. Public Health, 2013, 127(3): 247-251.
[8]
Hsu CS,Kao JH.Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan[J]. J Formos Med Assoc, 2012, 111(10): 527-535.
[9]
Vanni E,Bugianesi E,Kotronen A, et al.From the metabolic syndrome to NAFLD or vice versa[J]? Dig Liver Dis. 2010, 42(5): 320-330.
[10]
Dâmaso AR,do Prado WL,de Piano A, et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents[J]. Dig Liver Dis, 2008, 40(2): 132-139.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[5] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[6] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[7] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[8] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[9] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[10] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[11] 谢浩文, 丁建英, 刘小霞, 冯毅, 姚婧. 椎旁神经阻滞对微创胃切除肥胖患者术中血流、术后应激及康复质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 569-573.
[12] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[13] 中国医师协会外科医师分会肥胖代谢病综合管理与护理专家工作组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国肥胖代谢外科研究协作组. 肥胖代谢外科医学科普中国专家共识(2024 版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 227-234.
[14] 向林, 江云颂, 程吕佳, 关炳生, 杨景哥. 生长素释放肽在肥胖治疗中的潜在应用价值研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 235-241.
[15] 王鹏鹏, 周涵苓, 孟化, 刘宝胤. 减重手术后皮肤松弛的塑形手术现状与展望[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 248-254.
阅读次数
全文


摘要